MICREGEN

Following twenty years of scientific research and eighteen months of strategic planning, Micregen was founded in 2015. The proven team of leading business development, biotech industry and stem cell experts are focusing their research on the use of various stem cell types to develop several novel stem cell secretome therapeutics, collectively referred to as Secretomix®. Micregen's innovative approach and cutting-edge Secretomix® products aim to change how multiple age-related critical and chronic conditions are managed... The CEO & CSO founded Micregen together in 2015 with a leading team of biotech industry and stem cell experts with the goal of making secretome treatment more widely available. Micregen's aim is to tackle the root cause of degenerative conditions associated with ageing rather than merely treating the symptoms... Micregen has a unique understanding of how stem cells can be manipulated to produce potent stem cell secretions, known as Secretomix.

Primary location: Alderley Edge United Kingdom